Effectiveness and safety of herbal medicines in the treatment of irritable bowel syndrome: a systematic review.

World Journal of Gastroenterology : WJG
Jun ShiHai-Xia Li

Abstract

To explore the efficacy and safety of herbal medicines (HM) in the treatment of irritable bowel syndrome (IBS). A computer-based as well as manual literature search was performed. We reviewed randomized controlled trials on the treatment of IBS with and without HM. A total of 22 studies with 25 HMs met the inclusion criteria. Four of these studies were of good quality, while the remaining 18 studies involving 17 Chinese herbal medicine (CHM) formulas were of poor quality. Eight of these reports using 9 HMs showed global improvement of IBS symptoms, 4 studies with 3 HMs were efficacious in diarrhea-predominant IBS, and 2 studies with 2 HMs showed improvement in constipation-predominant IBS. Out of a total of 1279 patients, 15 adverse events in 47 subjects were reported with HM. No serious adverse events or abnormal laboratory tests were observed. The incidence of the adverse events was low (2.97%; 95% CI: 2.04%-3.90%). Herbal medicines have therapeutic benefit in IBS, and adverse events are seldom reported in literature. Nevertheless, herbal medicines should be used with caution. It is necessary to conduct rigorous, well-designed clinical trials to evaluate their effectiveness and safety in the treatment of IBS.

References

Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
Nov 20, 1998·JAMA : the Journal of the American Medical Association·A BensoussanM Ngu
Aug 24, 1999·Gut·W G ThompsonS A Müller-Lissner
Dec 10, 1999·The American Journal of Medicine·J Hammer, N J Talley
Jun 19, 2001·The Cochrane Database of Systematic Reviews·J P LiuH Lin
Feb 13, 2003·Archives of Internal Medicine·Jennifer A SpanierMichael P Jones
Oct 3, 2003·The New England Journal of Medicine·Anthony Lembo, Michael Camilleri
Mar 15, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Marshall PitzCharles N Bernstein
Mar 16, 2005·British Medical Bulletin·Robin C Spiller
May 3, 2005·Gastroenterology Clinics of North America·Filippo Cremonini, Nicholas J Talley
May 27, 2005·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·K-A Gwee
May 27, 2005·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·S M PatelA J Lembo
Nov 4, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Charles N Bernstein

❮ Previous
Next ❯

Citations

May 2, 2009·Chinese Journal of Integrative Medicine·Zhi-peng Tang
Dec 25, 2012·Chinese Journal of Integrative Medicine·Azar Asadi-ShahmirzadiMohammad Abdollahi
Dec 23, 2008·BMC Complementary and Alternative Medicine·Lynsey R Harris, Lesley Roberts
Mar 22, 2013·World Journal of Gastrointestinal Pharmacology and Therapeutics·Bruno M BalsigerJuergen M Gschossmann
Mar 12, 2013·Clinical Medicine : Journal of the Royal College of Physicians of London·Paul PosadzkiEdzard Ernst
May 24, 2011·Gastroenterology Clinics of North America·Donald N TsynmanJoyann A Kroser
Feb 22, 2011·Gastroenterology Clinics of North America·Suma Magge, Anthony Lembo
Apr 5, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Qing LiJian-Ping Liu
Jan 13, 2015·The American Journal of Chinese Medicine·Hai-Tao XiaoZhao-Xiang Bian
Apr 29, 2015·The American Journal of Chinese Medicine·Chun-Yan LiShu-Chuen Li
Nov 28, 2002·Gastroenterology·Douglas A DrossmanWilliam E Whitehead
Oct 21, 2009·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·David KieferKathryn Klunk
Mar 11, 2011·European Journal of Gastroenterology & Hepatology·Paul EnckUte Martens
Jun 23, 2009·Journal of the Chinese Medical Association : JCMA·Full-Young Chang, Ching-Liang Lu
Sep 18, 2020·Immunity, Inflammation and Disease·Guanqun Chao, Shuo Zhang
Mar 6, 2015·World Journal of Gastroenterology : WJG·Chun-Yan Li, Shu-Chuen Li
Jul 12, 2019·Journal of the Canadian Association of Gastroenterology·Paul MoayyediStephen Vanner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.